Written by Ad OpsOverview and Naming Clarity
Medi GOMI is a modern, multi-heritage cannabis cultivar bred by MadCat's Backyard Stash, a boutique breeder known for small-batch selections and hands-on phenohunting. The strain name often prompts confusion with similarly named European releases, but Medi GOMI is its own project, grounded in a ruderalis–indica–sativa backbone selected for balanced usability and dependable garden performance. The inclusion of ruderalis suggests a day-neutral, autoflower-leaning architecture, while the indica–sativa components supply structure, resin, and nuanced aromatics.
From a consumer standpoint, Medi GOMI aims to bridge functional daytime clarity with approachable body relief. Anecdotal grow logs report compact plants, rapid maturation, and forgiving nutrient needs compared to photoperiod counterparts. For patients and wellness users, the Medi label signals a formulation intended for steady mood support and physical comfort rather than couch-lock intensity.
Because the strain circulates through small craft channels, lab-verified potency and terpene numbers can vary across batches. In the broader context of comparable balanced autos, total cannabinoids often cluster in the 15 to 22 percent range by dry weight, with some THC-dominant phenotypes surpassing 22 percent under optimized conditions. Terpene totals in well-grown autos commonly land between 1.2 and 2.5 percent by weight, a range that aligns with user reports of pronounced aroma and flavor in Medi GOMI.
History and Breeding Background
MadCat's Backyard Stash developed Medi GOMI to deliver a practical, garden-friendly cultivar that still meets modern expectations for flavor and resin production. Many ruderalis-inclusive projects prioritise speed at the cost of depth, but this line reflects a more mature breeding approach—selecting progeny that keep autos fast while building terpene density and secondary cannabinoids. The result is a plant that finishes quickly yet rarely feels underdeveloped on the palate.
The breeding philosophy behind Medi GOMI centers on crossing stabilized auto stock with vigorous indica–sativa hybrids and then back-crossing to lock in day-neutral flowering. This approach historically increases uniformity in time-to-harvest while maintaining a range of aromatic expressions. Growers who have worked with similar MadCat lines report a deliberate focus on structural integrity—thicker branch angles and less larf in the lower thirds of the canopy.
Medi GOMI’s development coincides with a broader trend in the market since 2019 toward high-utility autos that rival photoperiods in both potency and yield. Indoor grows with optimized PPFD and training often report competitive production metrics compared to compact photoperiods, particularly when grown in 18 to 20 hours of light. As medical consumers increasingly seek balanced chemotypes, autos like Medi GOMI have carved out a niche for consistent, predictable outcomes across varied environments.
Genetic Lineage and Phenotypic Variability
The declared heritage of Medi GOMI is ruderalis–indica–sativa, a triad that typically yields rapid onset of flowering, balanced morphology, and a mosaic of terpene expressions. Ruderalis supplies the day-neutral flowering trait, meaning the plant initiates bloom by age rather than night length. The indica component generally contributes stockier frames, fast resin onset, and broader leaves, while the sativa element elongates internodes, brightens headspace, and lifts the top-note aromatics.
In practical terms, growers can expect two dominant phenotypic lanes. One leans indica with dense, golf-ball colas, reduced internodal spacing, and a heavier myrcene–beta-caryophyllene terpene bias. The second leans sativa with a taller central spear, more lateral branching, and a terpene tilt toward terpinolene or ocimene that often smells brighter and more herbal.
Chemotype variation follows the typical distribution seen in mixed-auto lines. A sizable portion presents THC-dominant flower in the 18 to 24 percent THC zone with trace CBD under 1 percent. A meaningful minority expresses balanced ratios, such as 1:1 to 2:1 THC:CBD, often in the 6 to 12 percent THC and 6 to 10 percent CBD ranges, which many medical users prefer for all-day functionality.
Appearance and Morphology
Medi GOMI plants often top out at 60 to 100 centimeters indoors depending on pot size, light intensity, and training. Autoflower physiology promotes a strong apical cola in early stages, but the line responds well to gentle low-stress training to open the canopy. Internodal spacing is moderate, enabling efficient light penetration with minimal defoliation.
Expect medium-green foliage with occasional purple petioles when night temperatures run 4 to 6 degrees Celsius cooler than day. Trichome coverage is assertive from week three of flower onward, and mature resin heads generally appear bulbous with consistent cloudiness at peak ripeness. Bract swell is noticeable late, giving buds a textured, craggy surface that resists airy formation when environmental conditions are in range.
Dry flowers cure into compact, resinous nuggets with visible capitate-stalked trichomes and a frost ring along sugar leaves. Calyx-to-leaf ratios are better than average for auto hybrids, easing trim time and preserving yield. Pistils mature from pale peach to amber rust near harvest, with darker hues indicating the later side of peak cannabinoid expression.
Aroma and Terpene Bouquet
Fresh Medi GOMI plants typically project a layered bouquet that blends earthy spice with bright herb and soft fruit. Early flower stages lean green and herbal, then pivot to a deeper resin note as trichome heads mature. In phenotypes with a higher terpinolene fraction, the nose can skew toward citrus-rind and apple-skin freshness.
Dominant terpenes reported in similar auto lines include beta-caryophyllene, myrcene, and limonene, often constituting 0.3 to 0.9 percent each by weight within a 1.2 to 2.5 percent total terpene envelope. Supporting actors like humulene, linalool, ocimene, and terpinolene frequently appear in the 0.05 to 0.4 percent band, shifting the bouquet from spice-forward to orchard-bright. When dried and cured correctly at 58 to 62 percent relative humidity, the bouquet becomes more articulate and less grassy as chlorophyll degrades.
The curing window has an outsized influence on Medi GOMI’s perfume. A slow dry targeting 10 to 14 days at 18 to 20 degrees Celsius reduces green volatiles and preserves monoterpenes, which are more volatile than sesquiterpenes. Multiple growers report that a four-week jar cure with periodic burping accentuates citrus, sweet pine, and a peppery base note that pairs well with the cultivar’s balanced effect profile.
Flavor and Palate
On the palate, Medi GOMI tends to open with lemon-peel zest and sweet herbs, followed by a mid-palate of cracked pepper and light cedar. The finish lingers with gentle pine, a hint of dried mango, and a low earthy resonance. Vaporization at 180 to 190 degrees Celsius emphasizes the citrus-herbal top notes and deemphasizes pepper.
Combustion brings out more caryophyllene-derived spice and deepens the cedar-wood impression, especially in phenotypes with higher humulene. Users often describe the aftertaste as clean and slightly sweet, with minimal bitter tannin when the cure is complete. Harshness is typically related to incomplete dry or elevated nitrogen late in flower rather than the cultivar’s inherent chemistry.
In blind tastings of comparable balanced autos, participants consistently rated high-limonene phenotypes as brighter and more refreshing, scoring flavor 0.4 to 0.7 points higher on 10-point scales than myrcene-dominant peers. Medi GOMI’s flavor span allows both preferences to coexist across phenotypes, which is part of its appeal to small-batch producers. Pairings that work well include citrus teas, mild cheeses, and roasted nuts that complement the pepper-citrus dynamic.
Cannabinoid Profile and Potency
Because Medi GOMI circulates primarily through craft channels, lab numbers will reflect breeder cut, environment, and harvest timing. In the context of similar ruderalis–indica–sativa autos, indoor THC-dominant phenotypes frequently test in the 18 to 24 percent THC window, with exceptional runs reaching 25 percent. Balanced phenotypes are commonly measured at 6 to 12 percent THC with 6 to 10 percent CBD, delivering total cannabinoids in the 14 to 20 percent range by weight.
Minor cannabinoids present opportunities for more nuanced effects. In autos, cannabigerol—CBG—often appears at 0.2 to 1.0 percent, depending on harvest date and genetic expression. Trace cannabinol—CBN—typically remains under 0.2 percent in fresh flower but can rise during storage or extended cure as THC oxidizes.
The harvest window strongly influences potency. Cutting at a 5 to 10 percent amber trichome ratio usually maximizes THC while maintaining a crisp terpene profile, whereas pushing beyond 20 percent amber commonly softens head effects and increases sedative qualities. Across autos grown under 18 to 20 hours of light, a seed-to-harvest timeline of 70 to 85 days tends to capture peak potency while limiting cannabinoid degradation.
Terpene Profile and Minor Compounds
Expect a terpene stack led by beta-caryophyllene and myrcene with notable contributions from limonene. In lab reports for comparable autos, these three can account for 45 to 70 percent of the total terpene fraction, translating to roughly 0.6 to 1.4 percent combined by dry weight under terp totals of 1.2 to 2.5 percent. Caryophyllene binds to CB2 receptors, which may help explain the perceived body ease many users report.
Humulene, linalool, and terpinolene often fill out the mid-spectrum. Humulene—structurally related to caryophyllene—adds woody dryness and may modulate appetite impressions when present above 0.1 percent. Linalool at 0.05 to 0.25 percent can tilt the experience toward calm, while terpinolene or ocimene deliver the vivid, green-bright lift associated with the sativa side.
Sulfur-containing thiols and esters, even in trace parts-per-billion quantities, can shape uniqueness. Clean, low-temperature drying helps preserve monoterpenes like limonene and ocimene that otherwise volatilize quickly. Growers who maintain room temperatures below 20 degrees Celsius during the first three days of dry often report measurably stronger terp intensity on the final cure.
Experiential Effects and Onset
Medi GOMI’s experiential arc is generally described as balanced, with a clear-eyed onset and an even, body-centered follow-through. Inhalation routes typically onset within 2 to 5 minutes, peak around 25 to 40 minutes, and taper over 2 to 3 hours, depending on tolerance and dose. Vaporized flower yields a crisper, more alert headspace, while combustion can deepen physical relaxation.
THC-dominant phenotypes skew more euphoric and creative in the first hour, often paired with light somatic warmth and loosening of shoulder and neck tension. Balanced 1:1 phenotypes present a flatter, steadier curve with less anxiety reactivity at moderate doses—common session ranges are 5 to 15 milligrams combined THC and CBD for many infrequent consumers. Exceeding 20 to 30 milligrams of THC in single sittings increases reports of short-lived tachycardia or unease in sensitive users.
Across user logs for comparable mixed autos, daytime suitability ratings are high, with 60 to 75 percent of respondents describing the effect as functional or semi-functional rather than couch-lock. Evening use remains popular due to the easy landing, especially with later-harvest flower that leans slightly more sedative. Music, light creative work, and gentle movement are frequently cited as ideal pairings.
Potential Medical Uses and Evidence
The Medi naming convention reflects the breeder’s intent to support wellness-oriented use cases, especially in balanced phenotypes that temper THC with CBD. Users often report relief in domains like stress reactivity, generalized anxieties, low-grade musculoskeletal discomfort, and sleep onset latency. In survey data across medical cannabis populations, balanced THC:CBD products are repeatedly associated with improved tolerability and reduced incidence of adverse events compared to THC-only products at the same total cannabinoid dose.
Evidence summaries from large reviews indicate moderate-quality support for cannabinoids in chronic pain reduction, with many trials showing small-to-moderate effect sizes. THC may provide primary analgesia and mood lift, while CBD can modulate THC’s psychoactivity and contribute to anxiolytic tone. For sleep, low-to-moderate THC doses often shorten sleep latency, whereas excessive doses can fragment architecture; CBD appears biphasic, with moderate amounts improving restfulness in some cohorts.
For practical dosing, balanced flower or extracts in the 1:1 to 2:1 THC:CBD range are commonly favored for daytime pain and stress. Starting doses around 2.5 to 5 milligrams THC and an equal or greater amount of CBD are typical for new patients, with titration by 1 to 2 milligrams every 1 to 2 days until desired effect is reached. Individuals with cardiac, psychiatric, or polypharmacy concerns should consult a clinician due to potential interactions—CBD can inhibit CYP450 enzymes, and THC may transiently elevate heart rate.
Comprehensive Cultivation Guide
Medi GOMI’s ruderalis component makes it a prime candidate for fast, efficient cultivation, especially indoors under extended light cycles. Most growers will see seed-to-harvest times between 70 and 85 days, with early-finishing phenotypes wrapping in as little as 65 days. Autos perform best without heavy topping; opt for low-stress training during days 14 to 28 to spread the canopy without delaying growth.
Environment and lighting are the two biggest levers for quality. Aim for 24 to 28 degrees Celsius day and 18 to 22 degrees Celsius night temperatures, with relative humidity at 60 to 65 percent in early veg, 50 to 55 percent mid-flower, and 45 to 50 percent late flower. This corresponds to a VPD target of approximately 0.9 to 1.2 kPa in veg and 1.2 to 1.5 kPa in flower, which supports gas exchange without over-drying the canopy.
Light intensity should target 500 to 700 µmol per square meter per second in early flower and 700 to 900 µmol in late flower for autos, delivering daily light integrals of roughly 35 to 45 mol per square meter per day. Many growers run 18 to 20 hours of light from sprout to chop for simplicity and robust photosynthesis, though 20 on and 4 off often nets slightly faster bulk in Medi GOMI due to reliable dark-period respiration. Keep LEDs 30 to 45 centimeters above the canopy when in the 700 to 900 PPFD range to avoid photobleaching.
Media and nutrition are straightforward. In soil, maintain pH 6.2 to 6.8; in coco or hydro, keep pH 5.8 to 6.2. Electrical conductivity in autos is best kept moderate—EC 1.2 to 1.6 in veg and 1.6 to 2.0 in bloom—because overfeeding can stunt ruderalis-leaning plants without adding yield.
Nitrogen should taper after week three of flower to prevent chlorophyll harshness and to encourage proper senescence. Phosphorus and potassium need to rise relative to nitrogen in bloom, with Ca and Mg support—100 to 150 ppm Ca and 40 to 60 ppm Mg—particularly important under LEDs to prevent interveinal chlorosis and brittle stems. A weekly root-zone flush with 5 to 10 percent runoff can mitigate salt buildup in coco and soilless mixes.
Pot sizing influences final height and yield. Autos like Medi GOMI commonly perform well in 11 to 19 liter containers—3 to 5 gallons—for indoor runs, with 2 to 4 plants per square meter depending on training. Outdoor, 20 to 40 liter fabric pots paired with at least 14 hours of summer daylight can produce compact bushes that finish before early fall rains.
Training should be gentle to capitalize on the cultivar’s innate timing. Begin low-stress training around day 14 by anchoring the main st
